These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12954072)

  • 1. New bivalent PKC ligands linked by a carbon spacer: enhancement in binding affinity.
    Sridhar J; Wei ZL; Nowak I; Lewin NE; Ayres JA; Pearce LV; Blumberg PM; Kozikowski AP
    J Med Chem; 2003 Sep; 46(19):4196-204. PubMed ID: 12954072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C.
    Giorgione J; Hysell M; Harvey DF; Newton AC
    Biochemistry; 2003 Sep; 42(38):11194-202. PubMed ID: 14503869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta.
    Nakagawa Y; Irie K; Yanagita RC; Ohigashi H; Tsuda K; Kashiwagi K; Saito N
    J Med Chem; 2006 May; 49(9):2681-8. PubMed ID: 16640328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New amide-bearing benzolactam-based protein kinase C modulators induce enhanced secretion of the amyloid precursor protein metabolite sAPPalpha.
    Kozikowski AP; Nowak I; Petukhov PA; Etcheberrigaray R; Mohamed A; Tan M; Lewin N; Hennings H; Pearce LL; Blumberg PM
    J Med Chem; 2003 Jan; 46(3):364-73. PubMed ID: 12540236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J; Deng F; Li J; Wang QJ
    Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of series of isobenzofuranone dimers as PKCalpha ligands: implication for the distance between the two ligand binding sites.
    Baba Y; Mayumi S; Hirai G; Kawasaki H; Ogoshi Y; Yanagisawa T; Hashimoto Y; Sodeoka M
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2969-72. PubMed ID: 15125970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkyl cinnamates as regulator for the C1 domain of protein kinase C isoforms.
    Mamidi N; Gorai S; Sahoo J; Manna D
    Chem Phys Lipids; 2012 Apr; 165(3):320-30. PubMed ID: 22414757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
    Baba Y; Ogoshi Y; Hirai G; Yanagisawa T; Nagamatsu K; Mayumi S; Hashimoto Y; Sodeoka M
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2963-7. PubMed ID: 15125969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T; Itagaki K; Irie K
    Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the membrane targeting C1 subdomains of PKC with bivalent ligands.
    Nowak I
    Curr Top Med Chem; 2007; 7(4):355-62. PubMed ID: 17305577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual C1 domains of PKD3 in phorbol ester-induced plasma membrane translocation of PKD3 in intact cells.
    Anderson G; Chen J; Wang QJ
    Cell Signal; 2005 Nov; 17(11):1397-411. PubMed ID: 15927450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Bögi K; Lorenzo PS; Szállási Z; Acs P; Wagner GS; Blumberg PM
    Cancer Res; 1998 Apr; 58(7):1423-8. PubMed ID: 9537243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
    Neumeyer JL; Zhang A; Xiong W; Gu XH; Hilbert JE; Knapp BI; Negus SS; Mello NK; Bidlack JM
    J Med Chem; 2003 Nov; 46(24):5162-70. PubMed ID: 14613319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the hydrophobic n-alkanol binding site within the C1 domains of protein kinase Calpha.
    Slater SJ; Malinowski SA; Stubbs CD
    Biochemistry; 2004 Jun; 43(23):7601-9. PubMed ID: 15182202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C isozymes and their selectivity towards ruboxistaurin.
    Tang S; Xiao V; Wei L; Whiteside CI; Kotra LP
    Proteins; 2008 Jul; 72(1):447-60. PubMed ID: 18214957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
    Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
    J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB; Enyedy IJ; Qiao L; Zhao L; Ma D; Pearce LL; Lorenzo PS; Stone JC; Blumberg PM; Wang S; Kozikowski AP
    J Med Chem; 2002 Feb; 45(4):853-60. PubMed ID: 11831896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity.
    Irie K; Nakahara A; Nakagawa Y; Ohigashi H; Shindo M; Fukuda H; Konishi H; Kikkawa U; Kashiwagi K; Saito N
    Pharmacol Ther; 2002; 93(2-3):271-81. PubMed ID: 12191619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.